June 12, 2024
Close this search box.

Celebrating Celiac Awareness with Schär’s Innovations

Celebrating Celiac Awareness with Schär's Innovations (2)

Schär Leads Celiac Awareness Month with Focus on Gluten-Free Innovation and Community Engagement

Celebrating Celiac Awareness with Schär's Innovations
Photo Courtesy: Schär

Swedesboro, NJ / May 2024 / This May, Schär, a global leader in gluten-free food innovation, is gearing up to celebrate Celiac Awareness Month by engaging in various activities aimed at increasing awareness, supporting the celiac disease community, and demonstrating its commitment to advancing research and education in gluten-related disorders.

Celiac Awareness Month serves as an important platform for individuals and organizations to come together to raise understanding and support for those living with celiac disease. Schär is proud to participate in initiatives led by the Celiac Disease Foundation and the National Celiac Association, including the “Shine a Light on Celiac Disease” campaign and the iCureCeliac Patient Registry campaign. These efforts seek to raise awareness about celiac disease, raise funds for research, and provide resources for individuals affected by the condition.

In addition to supporting these initiatives, Schär is actively involved in Digestive Disease Week (DDW), held in May in Washington, D.C. This premier conference brings together gastroenterologists, researchers, and other healthcare professionals to discuss the latest advancements in GI nutrition and celiac disease research. Schär’s products will be showcased at the Celiac Disease Foundation booth, allowing attendees to sample their delicious and nutritious gluten-free offerings.

Celiac Awareness Month holds special significance for Schär, a company dedicated to providing delicious and safe gluten-free options. For Schär, it’s an opportunity to raise awareness about celiac disease and highlight their ongoing commitment to supporting the celiac community and driving innovation in gluten-free food.

During DDW, Schär will participate in the annual Society for the Study of Celiac Disease meeting, engaging with leading experts and researchers in the field. This event offers a valuable opportunity for Schär to stay informed about the latest developments in celiac disease research and contribute to discussions on advancing diagnosis, treatment, and management of the condition.

As part of its commitment to education and support, Schär will host product giveaways throughout the month, providing individuals with the chance to try their high-quality gluten-free products. These giveaways not only offer delicious gluten-free options but also underscore Schär’s dedication to making gluten-free living easier and more enjoyable for everyone.

In addition to participating in Celiac Awareness Month activities, Schär remains focused on innovation, continually working to develop new and improved gluten-free products that meet the diverse needs and preferences of their customers. Through partnerships with leading organizations and ongoing research and development efforts, Schär continues to lead the way in gluten-free food innovation.

For more information about Schär and its involvement in Celiac Awareness Month, visit

About Schär

For more than 100 years, Dr. Schär’s mission has been to improve the lives of people with special nutritional needs. Dr. Schär USA, Inc. is committed to providing great-tasting gluten-free food to the celiac, gluten-sensitive sensitive and IBS communities—offering a safe, flavorful, and high-quality line of gluten-free products. Schär has over 20,000 doors in the US and retailers including Walmart, Kroger, Sprouts, Whole Foods, ShopRite, Stop & Shop, and many more. The complete product range includes bread, cookies, candy, and crackers, as well as frozen items like puff pastry dough and croissants. The introduction of soy-free Artisan Baker Breads further reinforces their dedication to earning the trust of consumers with food allergies.

Forward-Looking Statements

This release contains forward-looking statements regarding future operating and financial performance, product development, market position, and business strategy and objectives. These statements are based on current expectations of future events and are inherently subject to uncertainty. Actual results could vary materially from expectations and projections due to various factors. For a further list and description of these risks, uncertainties, and other factors, please refer to Dr. Schär’s filings with the SEC. Information in this release is as of the dates indicated herein, and Dr. Schär does not undertake to update any of the information contained in these materials, except as required by law. 

For media inquiries and interview opportunities, please contact:

Heather Holmes




Published by: Khy Talara

Share this article


This article features branded content from a third party. Opinions in this article do not reflect the opinions and beliefs of New York Wire.